Replek AD (XMAE:REPL) ROE % Adjusted to Book Value : 16.46% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Replek AD ROE % Adjusted to Book Value?

Replek AD's ROE % for the quarter that ended in Dec. 2024 was 29.95%. Replek AD's PB Ratio for the quarter that ended in Dec. 2024 was 1.82. Replek AD's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 16.46%.

Replek AD ROE % Adjusted to Book Value Historical Data

The historical data trend for Replek AD's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD ROE % Adjusted to Book Value Chart

Replek AD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

6.20

5.17

3.58

13.73

5.37

Replek AD Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	35.99	-	-	16.46

Competitive Comparison of Replek AD's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Replek AD's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Replek AD's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Replek AD's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Replek AD's ROE % Adjusted to Book Value falls into.

Replek AD ROE % Adjusted to Book Value Calculation

Replek AD's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	9.78%	/	1.82
	=	5.37%

Replek AD's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	29.95%	/	1.82
	=	16.46%

Replek AD ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Replek AD's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Replek AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kozle 188, Skopje, MKD

Website

https://www.replek.mk

Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.